middle.news
How 4DMedical’s CT:VQ™ Is Revolutionizing Lung Imaging After FDA Clearance
10:31am on Thursday 30th of October, 2025 AEDT
•
Healthcare
Read Story
How 4DMedical’s CT:VQ™ Is Revolutionizing Lung Imaging After FDA Clearance
10:31am on Thursday 30th of October, 2025 AEDT
Key Points
FDA clearance for CT, VQ™, first non-contrast CT-based ventilation-perfusion imaging
CMS reimbursement set at US$650.50 per scan, enabling rapid US market access
Stanford University first US academic medical centre to adopt CT, VQ™ commercially
Expansion of AstraZeneca partnership to six Brazilian hospitals covering 48,000 scans annually
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
4Dmedical (ASX:4DX)
OPEN ARTICLE